Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years

Ann Rheum Dis. 2015 Aug;74(8):e46. doi: 10.1136/annrheumdis-2015-207625. Epub 2015 Apr 10.

Authors

Motohisa Yamamoto¹, Teruhito Awakawa², Hiroki Takahashi¹

Affiliations

¹ Division of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Sapporo, Japan.
² Department of Internal Medicine and Gastroenterology, Sapporo Dohkohkai Hospital, Sapporo, Japan.

PMID: 25862615
DOI: 10.1136/annrheumdis-2015-207625

No abstract available

Keywords: B cells; Inflammation; Sjøgren's Syndrome.

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Murine-Derived / therapeutic use*
Antirheumatic Agents / therapeutic use*
Autoimmune Diseases / drug therapy*
Female
Humans
Immunoglobulin G / immunology*
Male

Substances

Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents
Immunoglobulin G